한글목차

아시아태평양의 고활성 API 시장 규모는 2023년 74억 9,000만 달러에서 2033년에는 256억 8,000만 달러에 달하며, 예측 기간의 2023-2033년 CAGR은 13.11%에 달할 것으로 예측됩니다.

암의 유병률 증가가 고활성 API의 수요를 촉진하고 있으며, 다양한 의학적 질환에서 이 고활성 API의 치료 용도 확대가 APAC 고활성 API 시장의 성장을 촉진하는 주요 요인입니다.

아시아태평양의 고활성 의약품 성분(HPAPI) 시장은 만성질환의 확산과 표적 치료제에 대한 수요 증가로 빠르게 성장하고 있으며, HPAPI는 특히 호르몬 불균형, 암 및 기타 특정 질환을 치료하는 데 있으며, 매우 강력한 약물을 만드는 데 중요한 역할을 하고 있습니다. 이 지역의 제약 산업이 발전하고 제조 능력과 기술이 향상됨에 따라 시장이 확대되고 있습니다.

이 같은 성장을 주도하고 있는 국가들은 강력한 인프라와 숙련된 인력, 그리고 성장을 가속하는 법적 프레임워크의 혜택을 누리고 있는 국가들입니다. 또한 수탁제조(CMO)의 성장과 R&D에 대한 투자 확대로 인해 시장의 잠재력은 더욱 커지고 있습니다.

아시아태평양의 고활성 API 시장에 대해 조사했으며, 국가별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

주요 요약

제1장 시장

• 동향 : 현재 및 향후 영향 평가
• 공급망/가치 개요
• 가격 분석
• 특허 출원 동향(연별, 국가별)
• 규제 상황
• 주요 세계 이벤트의 영향 분석-COVID-19
• 시장 역학 : 개요

제2장 지역

• 지역별 개요
• 아시아태평양

제3장 시장 - 경쟁 벤치마킹과 기업 개요

• 향후 전망
• 지역적 평가
  • Asymchem Inc.
  • Dr. Reddy's Laboratories Ltd.
  • CARBOGEN AMCIS

제4장 조사 방법

영문목차

Introduction to Asia-Pacific (APAC) Highly Potent API Market

The Asia-Pacific highly potent API market is projected to reach $25.68 billion by 2033 from $7.49 billion in 2023, growing at a CAGR of 13.11% during the forecast period 2023-2033. The increasing prevalence of cancer is driving the demand for highly potent APIs, and the expanding therapeutic applications of these potent APIs across a range of medical disorders are the main factors driving the growth of the APAC extremely potent API market.

Market Introduction

The market for highly potent active pharmaceutical ingredients (HPAPI) in Asia-Pacific is expanding quickly due to the growing prevalence of chronic illnesses and the growing need for targeted therapeutics. HPAPIs play a crucial role in the creation of extremely potent drugs, especially in the treatment of hormone imbalances, cancer, and other specific medical conditions. The market is growing thanks to the region's developing pharmaceutical industry, as well as improvements in manufacturing capacity and technology.

Leading the way in this expansion are nations which gain from strong infrastructure, highly skilled workers, and legislative frameworks that encourage growth. Additionally, the market's potential is being further enhanced by the growth of contract manufacturing organizations (CMOs) and greater investment in research and development. This research explores the APAC HPAPI market's future trends, key players, regulatory landscape, and current market dynamics, offering insightful information to stakeholders hoping to take advantage of new business possibilities in this rapidly expanding industry.

Market Segmentation

Segmentation 1: by Region

• China
• Japan
• India
• South Korea
• Australia
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Competitive Strategy: The Asia-Pacific highly potent API market has numerous established players with product and service portfolios. Key players in the Asia-Pacific highly potent API market analysed and profiled in the study involve established players offering product and services of highly potent API.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, type portfolio, and market penetration.

Some prominent names in the market include:

• Asymchem Inc.
• Dr. Reddy's Laboratories Ltd.
• CARBOGEN AMCIS

Table of Contents

Executive Summary

Scope and Definition

1 Markets

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Trend 1: Advancements in Containment Technologies for Highly Potent APIs
  • 1.1.2 Trend 2: Increasing Investment for Highly Potent API Manufacturing Units
  • 1.1.3 Trend 3: Pharmaceutical Companies Outsourcing Highly Potent APIs Production to CDMOs
• 1.2 Supply Chain /Value Overview
  • 1.2.1 Supply Chain and Risks within the Supply Chain
  • 1.2.2 Value Chain Analysis
• 1.3 Pricing Analysis
• 1.4 Patent Filing Trend (by Year, Country)
• 1.5 Regulatory Landscape
• 1.6 Impact Analysis for Key Global Events - COVID-19
• 1.7 Market Dynamics: Overview
  • 1.7.1 Market Drivers
    • 1.7.1.1 Increasing Incidence of Cancer Leading to Demand in the Adoption of Highly Potent APIs
    • 1.7.1.2 Advancements in Drug Delivery Technologies
    • 1.7.1.3 Expanding Therapeutic Applications of Highly Potent API
  • 1.7.2 Market Opportunities
    • 1.7.2.1 Growing Emphasis on Personalized Medicine
    • 1.7.2.2 Increasing Opportunities for Pharma Companies in Developing Markets
  • 1.7.3 Market Restraints
    • 1.7.3.1 Regulatory Complexity for Highly Potent APIs' Manufacturing
    • 1.7.3.2 High Development and Production Costs

2 Regions

• 2.1 Regional Summary
• 2.2 Asia-Pacific
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 China
  • 2.2.5 India
  • 2.2.6 Japan
  • 2.2.7 Australia
  • 2.2.8 South Korea
  • 2.2.9 Rest-of-Asia-Pacific

3 Markets -Competitive Benchmarking & Company Profiles

• 3.1 Next Frontiers
• 3.2 Geographic Assessment
  • 3.2.1 Asymchem Inc.
    • 3.2.1.1 Overview
    • 3.2.1.2 Key Developments
    • 3.2.1.3 Top Products/Product/Service Portfolio
    • 3.2.1.4 Top Competitors
    • 3.2.1.5 Key Personnel
    • 3.2.1.6 Analyst View
  • 3.2.2 Dr. Reddy's Laboratories Ltd.
    • 3.2.2.1 Overview
    • 3.2.2.2 Key Developments
    • 3.2.2.3 Top Products/Product/Service Portfolio
    • 3.2.2.4 Top Competitors
    • 3.2.2.5 Key Personnel
    • 3.2.2.6 Analyst View
  • 3.2.3 CARBOGEN AMCIS
    • 3.2.3.1 Overview
    • 3.2.3.2 Top Products/Product/Service Portfolio
    • 3.2.3.3 Key Developments
    • 3.2.3.4 Top Competitors
    • 3.2.3.5 Key Personnel
    • 3.2.3.6 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast